维普中文期刊产品整合服务
71篇 您的检索式:作者名="Chiostri"
    题名 作者 年代 出处 被引量
1Clinical significance of lactate in acute cardiac patients显示文摘Lactate, as a metabolite of easy and quick assessment, has been studied over time in critically ill patients in order to evaluate its prognostic ability. The present review is focused on the prognostic role of lactate levels in acute cardiac patients(that is with acute coronary syndrome, cardiogenic shock, cardiac arrest, non including post cardiac surgery patients). In patients with STelevation myocardial infarction treated with mechanical revascularization, hyperlactatemia identified a subset of patients at higher risk for early death and in-hospital complications, being strictly related mainly to hemodynamic derangement. The prognostic impact of hyperlactatemia on mortality has been documented in patients with cardiogenic shock and in those with cardiac arrest even if there is no cut-off value of lactate to be associated with worse outcome or to guide resuscitation or hemodynamic management. Therapeutic hypothermia seems to affect per se lactate values which have been shown to progressively decrease during hypothermia. The mechanism(s) accounting for lactate levels during hypothemia seem to be multiple ranging from the metabolic effects of reduced temperatures to the hemodynamic effects of hypothermia(i.e., reduced need of vasopressor agents). Serial lactate measurements over time, or lactate clearance, have been reported to be clinically more reliable than lactate absolute value also in acute cardiac patients. Despite differences in study design, timing of lactate measurements and type of acute cardiac conditions(i.e., cardiogenic shock, cardiac arrest, refractory cardiac arrest), available evidence strongly suggests that higher lactate levels can be observed on admission in non-survivors and that higher lactate clearance is associated with better outcome.Chiara Lazzeri Serafina Valente Marco Chiostri Gian Franco Gensini 2015World Journal of Cardiology2015,7,8:10
2Clinical significance of glycated hemoglobin in the acute phase of ST elevation myocardial infarction显示文摘In population-based studies,including diabetic and nondiabetic cohorts,glycated hemoglobin A1c(HbA1c) has been reported as an independent predictor of allcause and cardiovascular disease mortality.Data on the prognostic role of HbA1c in patients with acute myocardial infarction(MI) are not univocal since they stem from studies which mainly differ in patients' selection criteria,therapy(thrombolysis vs mechanical revascularization) and number consistency.The present review is focused on available evidence on the prognostic significance of HbA1c measured in the acute phase in patients with ST-elevation myocardial infarction(STEMI) submitted to primary percutaneous coronary intervention(PCI).We furthermore highlighted the role of HbA1c as a screening tool for glucose intolerance in patients with STEMI.According to available evidence,in contemporary cohorts of STEMI patients submitted to mechanical revascularization,HbA1c does not seem to be associated with short and long term mortality rates.However,HbA1c may represent a screening tool for glucose intolerance from the early phase on in STEMI patients.On a pragmatic ground,an HbA1c testhas several advantages over fasting plasma glucose or an oral glucose tolerance test in an acute setting.The test can be performed in the non-fasting state and reflects average glucose concentration over the preceding 2-3 mo.We therefore proposed an algorithm based on pragmatic grounds which could be applied in STEMI patients without known diabetes in order to detect glucose intolerance abnormalities from the early phase.The main advantage of this algorithm is that it may help in tailoring the follow-up program,by helping in identifying patients at risk for the development of glucose intolerance after MI.Further validation of this algorithm in prospective studies may be required in the contemporary STEMI population to resolve some of these uncertainties around HbA1c screening cutoff points.Chiara Lazzeri Serafina Valente Marco Chiostri Maria Grazia D'Alfonso Gian Franco Gensini 2014World Journal of Cardiology2014,6,4:2
3Postprocedural hyperglycemia in ST elevation myocardial infarction submitted to percutaneous coronary intervention:a prognostic indicator and a marker of metabolic derangement显示文摘Lazzeri C Chiostri M Sori a 2010J Cardiovasc Med(Hagerstown)2010,,11:1
4Correlates of acute insulin resistance in the early phase of non-diabetic ST-elevation myocardial infarction显示文摘Lazzeri C Valente S Chiostri M 2011Diab Vase Dis Res2011,8,1:1
5Uric acid in the early risk strat- ification of ST - elevation myocardial infarction 显示文摘Lazzeri C Valente S Chiostri M 2012Intern Emerg Med2012,7,1:1
6uric aciu in me acute phase of ST elevation myocardial infarction submitted to primary PCI: its prognostic role and relation with inflammatory markers: a single center experience 显示文摘Lazzeri C Yalente S Chiostri M 2010Int J Cardiol2010,138,2:1
7Prior and new onset anemia in ST-elevation myocardial infarction: a different prognostic role显示文摘VALENTE S LAZZERI C CHIOSTRI M 2011Intern Emerg Med2011,6,:1
8Uric acid in the acute phase of ST elevation myocardial infarction submitted to primary PCI:its prognostic role and relation with inflammatory markers:a single center experience显示文摘Lazzeri C Valente S Chiostri M 0,,:1
9Usefulness of Hyponatremia in the acute phase of ST-elevation myocardial infartion asc a marker of severity显示文摘Lazzeri C Valente S Chiostri M 2012Am J Cardiol2012,110,10:1
10Evaluation of acid–base balance in ST-elevation myocardial infarction in the early phase: a prognostic tool?显示文摘Chiara Lazzeri Serafina Valente Marco Chiostri Claudio Picariello Gian Franco Gensini 2010Coronary Artery Disease2010,,5:1
11Acid–base imbalance in uncomplicated ST-elevation myocardial infarction: the clinical role of tissue acidosis显示文摘Chiara Lazzeri Serafina Valente Marco Chiostri Claudio Picariello Gian Franco Gensini 2010Internal and Emergency Medicine2010,,1:1
12The glucose dysmetabolism in the acute phase of non-diabetic ST-elevation myocardial infarction: from insulin resistance to hyperglycemia显示文摘Chiara Lazzeri Serafina Valente Marco Chiostri Paola Attanà Claudio Picariello Gian Franco Gensini 2013Acta Diabetologica2013,,3:1
13Effects of two different treatments with continuous renal replacement therapy in patients with chronic renal dysfunction submitted to coronary invasive procedures显示文摘Spini V Cecchi E Chiostri M 2013J Invasive Cardiol2013,25,:1
14NT-proBNP on admission for early risk stratification in STEMI patients submitted to PCI. Relation with extension of STEMI and inflammatory markers显示文摘Serafina Valente Chiara Lazzeri Marco Chiostri Cristina Giglioli Andrea Sori Sabrina Tigli Gian Franco Gensini 2007International Journal of Cardiology2007,,1:1
15Effects of two different treatments with continuous renal replacement therapy in patients with chronic renal dysfunction submitted to coronary invasive procedures显示文摘Spini V Cecchi E Chiostri M 2013J Invasive Cardiol2013,25,2:1
16Impact of hypertension on short- and long-term prognoses in patients with ST elevation myocardial infarction and without previously known diabetes显示文摘Chiara Lazzeri Serafina Valente Marco Chiostri Paola Attanà Claudio Picariello Gian Gensini 2012Heart and Vessels2012,,4:1
17Evaluation of acid- base balance in ST-elevation myocardial infarction in the early phase: a prognostic tool显示文摘Lazzeri C Valente S Chiostri M 2010Coron Artery Dis2010,56,5:1
18Lactate clearance in cardio- genic shock following ST elevation myocardial infarction : a pilot study 显示文摘Attan6 P Lazzeri C Chiostri M 2012Acute Card Care2012,14,:1
19Trends in mortality rates in elderly ST elevation myocardial infarction patients submitted to primary percutaneous coronary intervention: a 7-year single-center experience 显示文摘Lazzeri C Valente S Chiostri M 2013Geriatr Gerontol Int2013,13,3:1
20Kinetic of procalcitonin in patients with cardiogenic shock following acute myocardial in- farction: preliminary data显示文摘Picariello C Lazzeri C Chiostri M 2010HSR Proc Intensive Care Cardio- vasc Anesth2010,2,3:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费